Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Der Nervenarzt
|
October 12, 2007
[Anticonvulsants in the treatment of anxiety--an alternative treatment option?]
P Zwanzger, D Eser, R Rupprecht
Der Nervenarzt
|
November 13, 2012
[Ketamine for treatment of therapy-resistant depression: a case study]
F Segmiller, D Frisse, D Eser, et al.
Pharmacology, Biochemistry, and Behavior
|
July 13, 2006
Neuroactive steroids and affective disorders
D Eser, C Schüle, T C Baghai, et al.
Der Nervenarzt
|
April 28, 2009
[Core symptoms of depression. Effectiveness of antidepressant therapy]
J Damm, D Eser, C Schüle, et al.
Neuroscience
|
March 29, 2011
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
C Schüle, D Eser, T C Baghai, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 22, 2008
Effects of experimentally induced panic attacks on neuroimmunological markers
L de la Fontaine, M J Schwarz, D Eser, et al.
Pharmacopsychiatry
|
November 20, 2009
Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder
P Zwanzger, D Eser, C Nothdurfter, et al.
Neuropsychobiology
|
December 18, 2008
Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients
S Haefner, T C Baghai, C Schule, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 27, 2003
Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety
P Zwanzger, H Jarry, D Eser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 18, 2003
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study
P Zwanzger, D Eser, S Aicher, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Der Nervenarzt
|
October 12, 2007
[Anticonvulsants in the treatment of anxiety--an alternative treatment option?]
P Zwanzger, D Eser, R Rupprecht
Der Nervenarzt
|
November 13, 2012
[Ketamine for treatment of therapy-resistant depression: a case study]
F Segmiller, D Frisse, D Eser, et al.
Pharmacology, Biochemistry, and Behavior
|
July 13, 2006
Neuroactive steroids and affective disorders
D Eser, C Schüle, T C Baghai, et al.
Der Nervenarzt
|
April 28, 2009
[Core symptoms of depression. Effectiveness of antidepressant therapy]
J Damm, D Eser, C Schüle, et al.
Neuroscience
|
March 29, 2011
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
C Schüle, D Eser, T C Baghai, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 22, 2008
Effects of experimentally induced panic attacks on neuroimmunological markers
L de la Fontaine, M J Schwarz, D Eser, et al.
Pharmacopsychiatry
|
November 20, 2009
Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder
P Zwanzger, D Eser, C Nothdurfter, et al.
Neuropsychobiology
|
December 18, 2008
Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients
S Haefner, T C Baghai, C Schule, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 27, 2003
Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety
P Zwanzger, H Jarry, D Eser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 18, 2003
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study
P Zwanzger, D Eser, S Aicher, et al.
Page
of 2